Thalidomide analogs as TNF-alpha modulators

Details for Australian Patent Application No. 2004274474 (hide)

Owner The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services Brossi, A. Giordano, T.

Inventors Greig, Nigel H.; Figg, William D.; Giordano, Tony; Brossi, Arnold; Zhu, Xiaoxiang; Holloway, Harold; Yu, Qian-Sheng

Agent Griffith Hack

Pub. Number AU-B-2004274474

PCT Pub. Number WO2005/028436

Priority 60/504,724 17.09.03 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 10 March 2011

International Classifications

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/46 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/84 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/86 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 211/88 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/028436 Priority application(s): WO2005/028436

24 February 2011 Alteration of Name

  The name of the applicant has been altered to The Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services; Brossi, A.; Giordano, T.

10 March 2011 Application Accepted

  Published as AU-B-2004274474

7 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274475-Novel adenosine A3 receptor agonists

2004274472-System and method for removing arsenite and arsenate from water